Evaluation of AMG 714 for Vitiligo
Public ClinicalTrials.gov record NCT04338581. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of AMG 714 for Vitiligo: A Phase 2a Randomized Double Blind Placebo Controlled Trial (ITN086AI)
Study identification
- NCT ID
- NCT04338581
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- AMG 714 Biological
- Placebo Biological
- nbUVB phototherapy Procedure
Biological · Procedure
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 10, 2020
- Primary completion
- Oct 15, 2024
- Completion
- Apr 1, 2025
- Last update posted
- Apr 20, 2026
2020 – 2025
United States locations
- U.S. sites
- 7
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, Irvine: Department of Dermatology | Irvine | California | 92697 | — |
| University of California Davis Health System: Department of Dermatology | Sacramento | California | 95816 | — |
| Yale University School of Medicine: Department of Dermatology | New Haven | Connecticut | 06520 | — |
| Tufts Medical Center: Department of Dermatology | Boston | Massachusetts | 02111 | — |
| University of Massachusetts Medical School | Worcester | Massachusetts | 01605 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Northwell Health | Lake Success | New York | 11042 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04338581, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04338581 live on ClinicalTrials.gov.